VaramirStart free · no cardSign in
BHVN as of Oct 31 · 15:51 ET
BHVNNYSEPharmaceutical Preparations

Biohaven Ltd. · Brief

Next report

128 days

Mar 8 · after closeest.Q4 FY26
Earnings

Expected move

Inputs

Implied vs realized

8 reportsHistory
0 of 8≥ implied
avg implied
±13.2%
avg realized
±4.3%
Mar 3 '25±13.2%▼−2.15%×0.16
May 12 '25±9.8%▼−5.11%×0.52
Aug 11 '25±10.9%▲+0.45%×0.04
Q3 FY25±14.4%▼−5.69%×0.39
Q1 FY26±17.6%▼−9.65%×0.55
May 4 '26±13.2%▼−4.24%×0.32
Q2 FY26±12.2%▼−0.34%×0.03
Q3 FY26±14.7%▼−6.49%×0.44
quarterimplied−20%0+20%realized×
Q3 FY26±14.7%▼−6.49%×0.44
Q2 FY26±12.2%▼−0.34%×0.03
May '26±13.2%▼−4.24%×0.32
Q1 FY26±17.6%▼−9.65%×0.55
Q3 FY25±14.4%▼−5.69%×0.39
Aug '25±10.9%▲+0.45%×0.04
2 older reports
May '25±9.8%▼−5.11%×0.52
Mar '25±13.2%▼−2.15%×0.16
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Mar 8 report · est.

—

Linked exposure

BHVN report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 29impliedImplied move: ±14.7% into Oct 29 earnings (Oct 29 close).Source
Oct 26impliedImplied move: ±16.3% into Nov 9 earnings (Oct 26 close).Source
Oct 158-KMaterial agreement: Collaboration and License Agreement with Ono Pharmaceutical Co., Ltd.Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.